BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 27422396)

  • 21. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VP1 B-C and D-E loops of bovine enterovirus cluster B can effectively display foot-and-mouth disease virus type O-conserved neutralizing epitope.
    Chang J; Li Y; Yang D; Wang F; Jiang Z; Yu L
    J Gen Virol; 2013 Dec; 94(Pt 12):2691-2699. PubMed ID: 24077365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.
    Yang M; Xu W; Goolia M; Zhang Z
    Virol J; 2014 Aug; 11():136. PubMed ID: 25085313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus.
    Yang M; Clavijo A; Suarez-Banmann R; Avalo R
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):126-34. PubMed ID: 17109972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
    Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
    J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
    Cui B; Liu X; Zhou P; Fang Y; Zhao D; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3367-3379. PubMed ID: 30888465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The detection of long-lasting memory foot-and-mouth disease (FMD) virus serotype O-specific CD4
    Mitoma S; Carr BV; Harvey Y; Moffat K; Sekiguchi S; Charleston B; Norimine J; Seago J
    Immunology; 2021 Oct; 164(2):266-278. PubMed ID: 34003490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
    Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
    J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
    Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
    Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus.
    Asfor AS; Upadhyaya S; Knowles NJ; King DP; Paton DJ; Mahapatra M
    J Gen Virol; 2014 May; 95(Pt 5):1104-1116. PubMed ID: 24584474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro.
    Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B
    Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.
    Cubillos C; de la Torre BG; Bárcena J; Andreu D; Sobrino F; Blanco E
    Virol J; 2012 Mar; 9():66. PubMed ID: 22416886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis.
    Bari FD; Parida S; Asfor AS; Haydon DT; Reeve R; Paton DJ; Mahapatra M
    J Gen Virol; 2015 May; 96(Pt 5):1033-1041. PubMed ID: 25614587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric foot-and-mouth disease virus serotype O displaying a serotype Asia1 antigenic epitope at the surface.
    Biswal JK; Ranjan R; Pattnaik B
    Biotechnol Lett; 2016 Sep; 38(9):1509-17. PubMed ID: 27160994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a conserved B-cell epitope on duck hepatitis A type 1 virus VP1 protein.
    Wu X; Li X; Zhang Q; Wulin S; Bai X; Zhang T; Wang Y; Liu M; Zhang Y
    PLoS One; 2015; 10(2):e0118041. PubMed ID: 25706372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
    Fernandez-Sainz I; Gavitt TD; Koster M; Ramirez-Medina E; Rodriguez YY; Wu P; Silbart LK; de Los Santos T; Szczepanek SM
    Vaccine; 2019 Jun; 37(26):3435-3442. PubMed ID: 31085001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
    Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.